BIIB

Biogen stock hits 52-week high at $202.64

Biogen stock hits 52-week high at $202.64  Investing.com

Biogen Stock On Fire: Up 6.6% With 7-Day Winning Streak

Biogen Stock On Fire: Up 6.6% With 7-Day Winning Streak  Trefis

Biogen Stock Rockets 6.6% With 7-Day Winning Streak

Biogen Stock Rockets 6.6% With 7-Day Winning Streak  Trefis

Biogen Inc (BIIB) Shares Surge 3.1% -- What GF Score of 77 Tells Investors

Biogen Inc (BIIB) Shares Surge 3.1% -- What GF Score of 77 Tells Investors  GuruFocus

Is Biogen Inc. (BIIB) one of the Best Biotech Stocks to Invest In According to Billionaire Steve Cohen?

Is Biogen Inc. (BIIB) one of the Best Biotech Stocks to Invest In According to Billionaire Steve Cohen?  Yahoo Finance UK

Biogen Inc. (BIIB) Stock Analysis: Potential 12% Upside Amid Strong Buy Ratings

Biogen Inc. (BIIB) Stock Analysis: Potential 12% Upside Amid Strong Buy Ratings  DirectorsTalk Interviews

Biogen Stock Gains Despite Extended FDA Review For Alzheimer's Therapy

Biogen Stock Gains Despite Extended FDA Review For Alzheimer's Therapy  Benzinga

FDA pushes back weekly Alzheimer's shot decision to Aug. 24

FDA pushes back weekly Alzheimer's shot decision to Aug. 24  Stock Titan

Biogen Had A Nearly Perfect Sales Sweep, But One Beat Really Stood Out

Biogen Had A Nearly Perfect Sales Sweep, But One Beat Really Stood Out  Investor's Business Daily

BIOGEN ($BIIB) Releases Q1 2026 Earnings

BIOGEN ($BIIB) Releases Q1 2026 Earnings  Quiver Quantitative

Biogen (BIIB) Reports Earnings Tomorrow: What To Expect

Biogen (BIIB) Reports Earnings Tomorrow: What To Expect  StockStory

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology  Biogen